A 2026 study in Metabolism: Clinical and Experimental asks a question most progress studies skip: what changes in the gut, not just the liver, as fatty liver turns into the inflamed form called MASH? The study fed mice a high-fat diet for 16 weeks to produce MASLD and 29 weeks to produce MASH, then measured metabolites, lipids, hormones, and cytokines across liver, colon, and stool. The finding is that the two stages are not the same disease at different severities - they have different gut signatures.
The useful headline is a specific one: in the early MASLD stage, the gut hormones GLP-1, GIP, and peptide YY were elevated, tracking with a rise in cholic acid and a bile-acid receptor called TGR5 in the colon. By the MASH stage, that hormone response was gone - replaced by broader inflammation and a serotonin signal in the liver. The body, in other words, mounts a hormonal compensation early, then loses it as the disease advances.
Why the stage-specific signal matters
The reason this matters is that it gives the gut hormones a timeline. GLP-1 is the same hormone the weight-loss medicines boost, and this study shows the body itself raises GLP-1 during early fatty liver - which is a clue that the early stage is, in part, the body trying to compensate before the compensation runs out. By MASH, the enterohormonal response is blunted and inflammation takes over. That is the difference between a disease that is being fought and one that has stopped fighting.
The honest boundary is the species: this is a mouse study, and the jump from a 16-week mouse to a human kitchen is long. The value is not a treatment a reader should chase - it is an understanding that the gut and the liver are having a conversation, and the conversation changes as the disease advances. That framing is the useful part, not a specific hormone to supplement.
The food side of a changing conversation
The food pattern the database rates is, at one level, the reader-facing version of the same gut-liver conversation. Fiber feeds the gut bacteria that shape the bile-acid and hormone signals the study measured; fermented and plant foods support the colonic environment where TGR5 and the enteroendocrine cells live. The Recommended column - vegetables, legumes, whole grains, fermented foods, olive oil, fatty fish - is the food side of keeping that conversation healthy for as long as possible.
The specific numbers make the plate concrete. Rolled oats sit in Recommended at about 10 grams of fiber per 100 grams; legumes and vegetables bring the fermentable fiber that feeds the gut; salmon carries omega-3s at roughly 1.3 grams of saturated fat per 100 grams. These are the foods the gut-liver axis responds to, and the study is one more reason the pattern is the default rather than a detail.
How our editorial team read this
We read mechanism studies with a discipline about species and stage. Our data editor verified this is a mouse study, kept the word "mice" in every claim, and did not translate a gut-hormone finding into a supplement or a medicine a reader should seek. We also kept the stage framing honest - the early compensation and the late loss are a mechanism story, not a prediction about any individual reader.
What we did do is connect the mechanism to the one lever that is real: the fiber and plant pattern that supports the gut side of the axis. The honest line is that the study explains why the gut matters, and the Recommended column is the food that keeps the gut conversation healthy.
The practical takeaway
For someone with fatty liver, the enterohormonal study is a reminder that the gut is not a bystander - it is part of the same disease, and the fiber-and-plant pattern is the food side of keeping it working. The database covers the plate; the clinician covers the staging; the study explains the mechanism in between.